Lancet

What Lancet does

Lancet is listed in available firmographics as a Netherlands-headquartered entity founded in 1999, based in Hilversum, with a stated headcount of 23 employees and a primary web domain of lancet.nl. The company's full legal name, corporate structure, ownership, and operational status are not disclosed in the source content reviewed. No industry vertical, product line, customer segment, or service category is identified anywhere in the input data.

The primary web property for the company — lancet.nl — is currently a TransIP domain registrar placeholder page. The page contains only generic registrar messaging (in Dutch and English), links to TransIP control panels, and standard knowledge-base articles for new domain owners. No company branding, product descriptions, service offerings, team information, customer references, news, or operational content is present on the domain. TransIP is identified as a Netherlands-based domain registrar founded in 2003; the placeholder indicates that the lancet.nl domain has been registered by a TransIP customer but does not provide any content about the registrant's business activity.

No product, technology, revenue model, pricing, customer, geographic market, partnership, certification, leadership, funding, M&A, or regulatory information could be verified from the input. The structured data sources explicitly mark revenue, company type, founded date, parent company, operating status, and product overview as unavailable or undeterminable. As a result, this description reflects only the limited firmographic footprint present in the data and the explicit absence of operational evidence on the company's own web property.

Name

Lancet

Website

https://lancet.nl

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Lancet is listed as a Netherlands-based entity founded in 1999, headquartered in Hilversum with 23 employees. No products, services, customers, or operational activity are documented; its web domain currently displays only a domain registrar placeholder.

Ownership category

akta.pro rank

Product category

Undetermined (no product/industry information available)

akta.pro primary industry

Lancing Devices & Lancets (HLAHAHAH)

Keywords

• Domain registration services
• Netherlands business services
• Small enterprise services
• Hilversum local business
• Registered domain holder

GTM type

B2B

Offering type

Services

Core offering

No information about Lancet's products or services is available from the source content. The lancet.nl website resolves to a TransIP domain-reservation placeholder page, and no operational offerings can be identified.

Product overview

Unable to determine from available source data. The source content is a TransIP reserved domain placeholder page for lancet.nl, not an official Lancet company website. The page contains only domain reservation information and generic TransIP branding, with no actual information about Lancet's products, services, or organizational structure.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Ypsomed: Swiss diabetes-care company offering lancing devices (e.g., mylife Clickfine) alongside broader injection and infusion systems. Comparable as an incumbent lancing-device player with a wider diabetes-care portfolio.
• LifeScan: OneTouch BGM brand owner offering meters, test strips, and lancing devices globally. Comparable incumbent in the diabetes monitoring space where Lancet's lancing products would compete.
• Trividia Health: US-based manufacturer of store-brand and TRUE brand BGM products including lancing devices. Comparable incumbent serving diabetes monitoring customers through retail and distribution.
• Ascensia Diabetes Care: Markets the CONTOUR portfolio of BGM systems and supplies lancing devices alongside meters and strips. Comparable broad incumbent serving the same diabetes customer segment.
• ARKRAY: Japanese diagnostics company producing BGM systems, test strips, and lancing devices for diabetes care. Comparable incumbent with overlapping specialty diagnostics portfolio.
• Roche Diabetes Care: Operates the Accu-Chek brand across BGM meters, strips, and lancing solutions. Serves the same diabetes end-user base with overlapping lancing-device offerings.

Emerging players

• AgaMatrix: Developer of BGM meters and WaveSense test strips; competes in adjacent diabetes-monitoring technology including lancing-related accessories. Comparable emerging player with partial overlap in capillary blood sampling.

Direct peers

• HTL-Strefa: Polish manufacturer specializing in lancets and safety lancets used in diabetes monitoring and clinical capillary sampling. Closely comparable niche lancing-device producer with overlapping product portfolio.
• Owen Mumford: UK-headquartered manufacturer of lancing devices and capillary blood-sampling products for diabetes diagnostics and clinical use. Highly comparable as a specialist in lancing-device technology serving similar end markets.
• SteriLance: Chinese manufacturer of sterile lancets, safety lancets, and capillary blood-collection devices. Direct product-line overlap and serves diabetes and clinical diagnostics customers.

Market position

Strengths2 records

Weaknesses3 records

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/lancet

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lancet